Replay available

Aspen Pharmacare Hldgs (APNHF) Q4 2025 Earnings Call

Aspen Pharmacare Hldgs (OTC: APNHF) Q4 2025 earnings conference call, held 2025-09-04. Replay captured from the company's public earnings webcast.

Thu, September 4, 2025 at 2:30 AMendedReplay
Aspen Pharmacare Hldgs (APNHF) Q4 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Sean Capizorio

Group Chief Financial Officer

Stephen Saad

Group Chief Executive Officer

Replay transcript excerpt

Good morning, ladies and gentlemen. A very warm welcome to Aspen's 2025 Annual Results Presentation. Thank you for joining us. To kick things off this morning, we'll start with Stephen Saad, our Group CEO, who will take us through the group's performance overview and highlights. Sean Capizorio, our Group CFO, will then take us through the financial results in some detail. Following that, Stephen will return to share Aspen's strategy, prospects, and guidance. Once the presentations have been concluded, we'll then move over to the question and answer session, and we encourage you to participate by typing in your questions at the top left side of the webcast page. With that, it's my pleasure to hand over to Stephen. Stephen, over to you. Thank you, Sunny. Thank you. Good morning, everyone. Good to be here and good to be talking to you. It's interesting and the car journey down here, I just made a few notes actually from there because you get a chance to reflect. We're so focused on what we're going to do in the next court and you sometimes have to wind back and think, well, listen, what happened in the past year? And I've been around a while and many of us have been around a while and the one thing that's indisputable I think is that Your journey of life, journey in business is always, it's never going to be a straight road. They always have some turns. But I would think that the events in the last three to four months of this year, to call what we're seeing a turn here is probably an understatement. You know, we've, the macro factors, within our world, I would call it extreme turbulence and actually it's not over and certainly not for the pharma industry, not over and it's continuing. So what we have focused on and what you'll see now is a plan which is one in which we...

More from Aspen Pharmacare Holdings Limited